ER heart drug trial aims to help seniors breathe easier
NCT ID NCT07392788
First seen Feb 06, 2026 · Last updated May 18, 2026 · Updated 10 times
Summary
This study looks at whether giving a drug called dapagliflozin (a gliflozin) early in the emergency room can help elderly patients (75 and older) who are hospitalized for worsening chronic heart failure. The trial will include 144 participants across 6 hospitals. The main goal is to see if this approach is practical and acceptable, not yet to prove it works. Patients will be followed for 3 months to check their health and safety.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE HEART FAILURE (AHF) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.